匹莫苯丹
匹莫苯丹用途
匹莫苯丹名称
[ CAS 号 ]:
74150-27-9
[ 中文名 ]:
匹莫苯
[ 英文名 ]:
Pimobendan
[中文别名 ]:
[英文别名 ]:
- (±)-UD CG 115BS
- dl-Pimobendan
- rac PiMobendan
- Vetmedin
- UD CG 115 BS
- Pimobendam
- Pimobendan
- Pimobendanum
- UD-CG 115
- UNII:34AP3BBP9T
匹莫苯丹生物活性
[ 描述 ]:
[ 相关类别 ]:
[参考文献]
[相关活性小分子]
匹莫苯丹物理化学性质
[ 密度 ]:
1.4±0.1 g/cm3
[ 熔点 ]:
249 °C(dec.)
[ 分子式 ]:
C19H18N4O2
[ 分子量 ]:
334.372
[ 精确质量 ]:
334.142975
[ PSA ]:
79.37000
[ LogP ]:
1.81
[ 外观性状 ]:
固体;White to Almost white powder to crystal
[ 折射率 ]:
1.693
[ 储存条件 ]:
0-10°C;存放于惰性气体之中;避免空气,加热
匹莫苯丹毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- UR6373000
- CHEMICAL NAME :
- 3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5- yl)-5-methyl-
- CAS REGISTRY NUMBER :
- 74150-27-9
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 15
- MOLECULAR FORMULA :
- C19-H18-N4-O2
- MOLECULAR WEIGHT :
- 334.41
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 950 mg/kg
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - other changes Endocrine - other changes
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 25,815,1994
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 72 mg/kg
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - acute pulmonary edema Gastrointestinal - other changes
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >2 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- >2 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 25,815,1994 ** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 16800 mg/kg/4W-I
- TOXIC EFFECTS :
- Endocrine - changes in adrenal weight Blood - normocytic anemia Related to Chronic Data - death
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1911 mg/kg/39W-I
- TOXIC EFFECTS :
- Gastrointestinal - other changes
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 18200 mg/kg/52W-I
- TOXIC EFFECTS :
- Gastrointestinal - other changes Blood - changes in other cell count (unspecified)
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 56 mg/kg/4W-I
- TOXIC EFFECTS :
- Gastrointestinal - other changes
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 1400 mg/kg/4W-I
- TOXIC EFFECTS :
- Skin and Appendages - dermatitis, other (after systemic exposure)
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 56 mg/kg/4W-I
- TOXIC EFFECTS :
- Cardiac - pericarditis
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,561,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 27300 mg/kg/26W-C
- TOXIC EFFECTS :
- Cardiac - change in rate Cardiac - other changes
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 42,529,1991 ** REPRODUCTIVE DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 24 gm/kg
- SEX/DURATION :
- male 8 week(s) pre-mating female 2 week(s) pre-mating - 7 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Effects on Embryo or Fetus - fetal death
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,415,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 390 mg/kg
- SEX/DURATION :
- female 17-21 day(s) after conception lactating female 21 day(s) post-birth
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,415,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1300 mg/kg
- SEX/DURATION :
- female 6-18 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
- REFERENCE :
- OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 43,415,1992
匹莫苯丹安全信息
[ 符号 ]:
GHS06
[ 信号词 ]:
Danger
[ 危害声明 ]:
H301
[ 警示性声明 ]:
Missing Phrase - N15.00950417
[ 危害码 (欧洲) ]:
Xi
[ 风险声明 (欧洲) ]:
R36/37/38:Irritating to eyes, respiratory system and skin .
[ 安全声明 (欧洲) ]:
S26-S37/39
[ 危险品运输编码 ]:
UN 2811 6.1 / PGIII
[ WGK德国 ]:
3
[ RTECS号 ]:
CY8980000
[ 海关编码 ]:
29310095
匹莫苯丹制备
在搅拌下,往二硫化碳、无水三氯化铝和乙酰苯胺的溶液中,缓慢滴加丙酰氯,回流。冷至室温,将下层反应液缓慢倒入碎冰中。滤集固体,乙醇重结晶,得化合物(I),收率51.3%。
二甲胺盐酸盐和36%甲醛溶液,室温反应。加入醋酐,搅拌至反应液澄清。然后加入化合物(Ⅰ),100℃反应。60~65℃下减压蒸出低沸物,加丙酮回流。蒸出丙酮,加水溶解,用二氯甲烷洗3次。水层再加二氯甲烷,冷却下用2.5mol/L,氢氧化钠中和至Ph=10。分出有机层,水层用二氯甲烷提取。合并有机层,用饱和盐水洗2次,干燥,浓缩。再和碘甲烷在丙酮中,室温反应。过滤,干燥,得化合物(Ⅱ)。 化合物(Ⅱ)溶于含水甲醇,再加入氰化钾的水溶液,室温搅拌。滤集固体,用大量水洗至无CN-离子,干燥,乙醇重结晶得化合物(Ⅲ),收率76.6%。
在搅拌和-5~0℃下,把化合物(Ⅲ)加到混酸中,反应。倾入碎冰中,加乙酸乙酯。滤集固体,水洗至中性,干燥,得化合物(Ⅳ),收率62.8%。
化合物(Ⅳ)和6mol/L盐酸,回流。冷至室温,过滤,干燥,得化合物(V),收率77.3%。
化合物(V)、95%乙醇和水合肼,搅拌回流。冷至室温,过滤,干燥,得化合物(VI),收翠92.3%。
化合物(Ⅵ)、对甲氧基苯甲酰氯和无水吡啶,40~50℃反应。倾入冷水中,滤集固体,干燥,然后和丙酮搅拌回流,冷至室温,过滤,干燥,得化合物(Ⅶ),收率51.4%。
化合物(Ⅶ)、10%钯-炭和95%乙醇,在0.49MPa的氢压下,振荡搅拌。过滤得化合物(Ⅷ)和钯-炭的混合物,可直接用于下步反应。母液回收的产物用丙酮-二甲基甲酰胺重结晶,可得化合物(Ⅷ)。
化合物(Ⅷ)和钯-炭的混合物在述雕酸中,回流。冷至室温,过滤。滤液加冰水,用25%氢氧化钠中和。滤集固体,干燥,用硅胶G柱层析,得匹莫苯,熔点175~178℃,收率68.7%[以化合物(Ⅶ)计]。往匹莫苯中滴加氯化氢饱和的乙醇,搅拌。滤集固体,干燥,得盐酸匹莫苯,收率79.4%,熔点>300℃。
方法2:乙酰苯胺、丙酰氯和三氯化铝在二硫化碳中反应,得化合物(I),收率76%。
化合物(I)、冰醋酸和溴反应,粗品经硅胶G柱层析,得化合物(Ⅱ),收率74%。
在冰浴搅拌下,往氢化钠的四氢呋喃中,缓慢滴加丙二酸二乙酯,反应。把该反应液加到化合物(Ⅱ)的四氢呋喃溶液中,室温搅拌。用2mol/L盐酸酸化至Ph=1,加入乙醚。分出有机层,水层用乙醚萃取3次。合并有机层,用饱和碳酸氢钠、氯化钠水溶液洗至中性,干燥。蒸出乙醚,用硅胶G柱层析,得化合物(Ⅲ),收率89.4%。
化合物(Ⅲ)经混酸硝化,粗品经硅胶G柱层析,得化合物(Ⅳ),收率89%。
化合物(Ⅱ)先经混酸硝化,再和丙二酸二乙酯反应,同样得化合物(Ⅳ),二步收率68.8%。
化合物(Ⅳ)溶于乙醇,加入5%氢氧化钠,70~80℃:搅拌。用3mol/L盐酸酸化至Ph=1,70~80℃再搅拌。冷至室温,加入乙酸乙酯。分出有机层,水层用乙酸乙酯提取3次。合并有机层,干燥。蒸出溶剂,用硅胶G柱层析,得化合物(V),收率85%。
化合物(V)溶于二苯醚,在160~170℃搅拌至无二氧化碳气泡放出。冷却,滤集固体,用少量石油醚洗,干燥得化合物(Ⅵ),收率82%。
化合物(Ⅵ)、无水乙醇和85%水合肼回流反应,得化合物(Ⅶ),收率92%。
化合物(Ⅶ)溶于无水乙醇,在5%钯-炭存在下,用85%水合肼在70~80℃还原后,再经硅胶G柱层析,得化合物(Ⅷ),收率88%。
在偏重亚硫酸钠、水和甲醇中,化合物(Ⅷ)和对甲氧基苯甲醛在25~60℃缩合,粗品经硅胶G柱层析,得匹莫苯,收率92%,熔点240~241℃(分解)(该熔点和方法1中匹莫苯的熔点有很大出入)。匹莫苯再和盐酸-乙醇饱和溶液反应,得盐酸匹莫苯,收率80%,熔点>310℃(分解)。
匹莫苯丹海关
[ 海关编码 ]: 29310095
匹莫苯丹文献
Bioorg. Med. Chem. 18 , 3985-91, (2010)
A series of 1H-benzo[d]imidazole analogues of Pimobendan, substituted at position 5 with either -CF(3) or -NO(2), were synthesized using a short synthetic route. All the nitro derivatives were potent,...
Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus).J. Zoo Wildl. Med. 45(4) , 987-90, (2014)
Abstract: An aquarium-housed, 6-mo-old African penguin (Spheniscus demersus) presented with acute respiratory distress. Auscultation revealed a grade II-III systolic murmur in the absence of adventiti...
Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.J. Cardiovasc. Pharmacol. 65(6) , 640-8, (2015)
This study was designed to assess the progression of pulmonary arterial hypertension (PAH) and the effectiveness of therapy using recently investigated echocardiographic parameters. PAH is characteriz...
相关药品:
推荐生产厂家/供应商:
公司名:上海源溪生物科技有限公司
区域:上海市浦东新区
价格:
¥需询单/1g
联系人:赖经理
产品详情:Pimobendan
公司名:上海脉铂医药科技有限公司
区域:上海市嘉定区
价格:
¥17279.0/200mg
¥1179.0/5mg
¥6779.0/50mg
¥1489.0/50g
联系人:李先生
产品详情:Pimobendan
公司名:上海阿拉丁生化科技股份有限公司
区域:上海市浦东新区
价格:
¥30.9/10mg
¥29.9/5mg
¥1144.9/1ml
¥92.9/50mg
联系人:阿拉丁李高志
产品详情:Pimobendan
公司名:上海创赛科技有限公司
区域:上海市嘉定区
价格:
¥752.0/250mg
¥1960.0/1g
¥16944.2/200mg
¥1166.2/5mg
联系人:夏言
产品详情:[Perfemiker]匹莫苯丹,97%
公司名:武汉敬康恩生物医药科技有限公司
区域:武汉市东西湖区
价格:
¥需询单/1g
联系人:周经理
产品详情:Pimobendan
查看所有供应商请点击:
相关化合物
【匹莫苯丹】化源网提供匹莫苯丹CAS号74150-27-9,匹莫苯丹MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询匹莫苯丹上化源网,专业又轻松。>>电脑版:匹莫苯丹
标题:匹莫苯丹_用途_密度_熔点_匹莫苯丹CAS号【74150-27-9】_化源网 地址:https://www.chemsrc.com/amp/cas/74150-27-9_832211.html